Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer - No Study Results Posted

Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer (SetPace)

This study is ongoing, but not recruiting participants.

Study NCT00770822 Information provided by USHIFU, LLC

First Received: October 9, 2008 Last Updated: July 20, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2011
Estimated Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)